uniQure
QURE
$4.54
Share price
-0.44%
Change (1 day)
-76.98%
Change (1 year)
Operating Margin for uniQure (QURE)
Operating Margin as of April 2024 (TTM): -120.45%
According to uniQure's latest financial reports and stock price the company's current Operating Margin is -120.45%. At the end of 2021 the company had an Operating Margin of 63.51%.
Operating Margin history for uniQure from 2014 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | 63.51% | -116.84% |
| 2020 | -377.04% | -77.9% |
| 2019 | -1,705.82% | 131.71% |
| 2018 | -736.20% | 21.44% |
| 2017 | -606.23% | 110.65% |
| 2016 | -287.79% | -62.28% |
| 2015 | -762.98% | -3.49% |
| 2014 | -790.61% | -13.25% |
| 2013 | -911.31% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | 34.59% | -128.72% | 🇺🇸 USA |
 Sanofi SNY | 18.21% | -115.12% | 🇫🇷 France |
 Sangamo Therapeutics
SGMO | -160.78% | 33.48% | 🇺🇸 USA |
 bluebird bio
BLUE | -7,407.86% | 6,050.15% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | 4.83% | -104.01% | 🇺🇸 USA |
 Avidity Biosciences RNA | -1,886.32% | 1,466.06% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.